Sensitivity to tumor development by TALEN-mediated Trp53 mutant genes in the susceptible FVB/N mice and the resistance C57BL/6 mice

被引:3
作者
Bin Yun, Woo [1 ,3 ]
Kim, Ji Eun [1 ]
Lee, Mi Lim [1 ]
Choi, Jun Young [1 ]
Park, Jin Ju [1 ]
Song, Bo Ram [1 ]
Kang, Byeong Cheol [2 ]
Nam, Ki Taek [3 ]
Lee, Han-Woong [4 ]
Hwang, Dae Youn [1 ]
机构
[1] Pusan Natl Univ, Coll Nat Resources & Life Sci, Dept Biomat Sci, BK21 FOUR Program, 50 Cheonghak Ri, Miryang Si 50463, Gyeongsangnam D, South Korea
[2] Seoul Natl Univ, Biomed Res Inst, Dept Expt Anim Res, Coll Med, Seoul 03080, South Korea
[3] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul 03722, South Korea
[4] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 03722, South Korea
基金
新加坡国家研究基金会;
关键词
Trp53; Tumorigenesis; TALEN; FVB; N; C57BL; 6; P53; SPECTRUM; TUMORIGENESIS; MECHANISMS; DEFICIENT; MODEL;
D O I
10.1186/s42826-021-00107-y
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background This study was undertaken to compare the sensitivities of mice strains during tumor induction by transcription activator-like effector nucleases (TALEN)-mediated Trp53 mutant gene. Alterations of their tumorigenic phenotypes including survival rate, tumor formation and tumor spectrum, were assessed in FVB/N-Trp53(em2Hwl)/Korl and C57BL/6-Trp53(em1Hwl)/Korl knockout (KO) mice over 16 weeks. Results Most of the physiological phenotypes factors were observed to be higher in FVB/N-Trp53(em2Hwl)/Korl KO mice than C57BL/6-Trp53(em1Hwl)/Korl KO mice, although there were significant differences in the body weight, immune organ weight, number of red blood cells, mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), platelet count (PLT), total bilirubin (Bil-T) and glucose (Glu) levels in the KO mice relative to the wild type (WT) mice. Furthermore, numerous solid tumors were also observed in various regions of the surface skin of FVB/N-Trp53(em2Hwl)/Korl KO mice, but were not detected in C57BL/6-Trp53(em1Hwl)/Korl KO mice. The most frequently observed tumor in both the Trp53 KO mice was malignant lymphoma, while soft tissue teratomas and hemangiosarcomas were only detected in the FVB/N-Trp53(em2Hwl)/Korl KO mice. Conclusions Our results indicate that the spectrum and incidence of tumors induced by the TALEN-mediated Trp53 mutant gene is greater in FVB/N-Trp53(em2Hwl)/Korl KO mice than C57BL/6-Trp53(em1Hwl)/Korl KO mice over 16 weeks.
引用
收藏
页数:13
相关论文
共 26 条
[1]   Mechanisms of p53-mediated apoptosis [J].
Bates, S ;
Vousden, KH .
CELLULAR AND MOLECULAR LIFE SCIENCES, 1999, 55 (01) :28-37
[2]   p53 isoforms can regulate p53 transcriptional activity [J].
Bourdon, JC ;
Fernandes, K ;
Murray-Zmijewski, F ;
Liu, G ;
Diot, A ;
Xirodimas, DP ;
Saville, MK ;
Lane, DP .
GENES & DEVELOPMENT, 2005, 19 (18) :2122-2137
[3]   p53 transcriptional activity is essential for p53-dependent apoptosis following DNA damage [J].
Chao, C ;
Saito, S ;
Kang, J ;
Anderson, CW ;
Appella, E ;
Xu, Y .
EMBO JOURNAL, 2000, 19 (18) :4967-4975
[4]   MICE DEFICIENT FOR P53 ARE DEVELOPMENTALLY NORMAL BUT SUSCEPTIBLE TO SPONTANEOUS TUMORS [J].
DONEHOWER, LA ;
HARVEY, M ;
SLAGLE, BL ;
MCARTHUR, MJ ;
MONTGOMERY, CA ;
BUTEL, JS ;
BRADLEY, A .
NATURE, 1992, 356 (6366) :215-221
[5]   EFFECTS OF GENETIC BACKGROUND ON TUMORIGENESIS IN P53-DEFICIENT MICE [J].
DONEHOWER, LA ;
HARVEY, M ;
VOGEL, H ;
MCARTHUR, MJ ;
MONTGOMERY, CA ;
PARK, SH ;
THOMPSON, T ;
FORD, RJ ;
BRADLEY, A .
MOLECULAR CARCINOGENESIS, 1995, 14 (01) :16-22
[6]  
Flecknell P., 2016, ANAESTHESIA COMMON L, V4
[7]  
Harel T., 2015, Rosenbergs Molecular and Genetic Basis of Neurological and Psychiatric Disease, P3, DOI [10.1016/ B978- 0-12-410529- 4.00001-2, DOI 10.1016/B978-0-12-410529-4.00001-2]
[8]   SPONTANEOUS AND CARCINOGEN-INDUCED TUMORIGENESIS IN P53-DEFICIENT MICE [J].
HARVEY, M ;
MCARTHUR, MJ ;
MONTGOMERY, CA ;
BUTEL, JS ;
BRADLEY, A ;
DONEHOWER, LA .
NATURE GENETICS, 1993, 5 (03) :225-229
[9]   GENETIC BACKGROUND ALTERS THE SPECTRUM OF TUMORS THAT DEVELOP IN P53-DEFICIENT MICE [J].
HARVEY, M ;
MCARTHUR, MJ ;
MONTGOMERY, CA ;
BRADLEY, A ;
DONEHOWER, LA .
FASEB JOURNAL, 1993, 7 (10) :938-943
[10]   P53 MUTATIONS IN HUMAN CANCERS [J].
HOLLSTEIN, M ;
SIDRANSKY, D ;
VOGELSTEIN, B ;
HARRIS, CC .
SCIENCE, 1991, 253 (5015) :49-53